Incresync 25/30mg is an oral antidiabetic combination therapy indicated to improve glycemic control in adults with type 2 diabetes mellitus. It contains alogliptin, a DPP-4 inhibitor, and pioglitazone, a thiazolidinedione. This dual-action formula works by improving insulin sensitivity and enhancing the body's natural ability to regulate blood sugar. Incresync is recommended as an adjunct to diet and exercise when single therapy is not sufficient. It helps reduce both fasting and post-meal blood glucose levels. The combination offers a convenient and effective option for patients requiring dual therapy. Each pack contains 28 film-coated tablets. . Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
